Zimmer Biomet Holdings, Inc. ZBH recently received Food and Drug Administration (“FDA”) Premarket Approval Application (“PMA”) Supplement approval for the Oxford Cementless Partial Knee.

Berend, MD “The complication rate, survival rate and functional outcome for cementless Oxford [unicompartmental knee arthroplasty ... They discovered partial tibial radiolucencies in 6% of ...

announced U.S. Food and Drug Administration (FDA) Premarket Approval Application (PMA) Supplement approval for the Oxford® Cementless Partial Knee. The approval is based on safety and ...

Kron considered getting his knees replaced, but Mark Davis, an orthopedic surgeon, said he didn’t need an entire knee replacement and could opt for another procedure called the Oxford Partial ...

Zimmer Biomet received FDA premarket approval for its Oxford cementless partial knee replacement implant. The implant first launched in England in 2004. The U.S. launch is expected in the first ...

Orthopedic surgeon Dr. Robert Malinzak recently performed the first partial knee replacement procedure in Indiana, at Ascension St. Vincent Fishers Hospital, using the Oxford Cementless Partial ...

Partial knee replacement surgery is safer than total knee replacement, according to a new study published in The Lancet. A team of researchers from the University of Oxford, funded by Arthritis ...

Pune: More than 100 orthopaedic surgeons from India participated in the Oxford partial knee course conducted by the Oyster and Pearl Hospital, Pune recently. Orthopaedic surgeons Chris Dodd and ...

PARTIAL knee replacements in place of total knee replacements could benefit patients and save the NHS cash, according to new Oxford research. An Oxford University study published yesterday ...

The approval is based on safety and effectiveness data from an Investigational Device Exemption (IDE) study and non-clinical testing for cementless partial knee replacement (PKR).1 The Oxford ...

Partial knee replacement surgery is safer than total knee replacement, according to a new study published in The Lancet today (July 8). A team of researchers from the University of Oxford ...

WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug ...